CORRESP Filing
Benitec Biopharma Inc.
Date: May 29, 2025 · CIK: 0001808898 · Accession: 0001193125-25-130616
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287566
Letter
Re: Benitec Biopharma Inc. Registration Statement on Form S-3 ( File No. 333-287566) Dear Mr. Drory: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287566) so that it may become effective at 4:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable.
BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD, CALIFORNIA 94545 May 29, 2025 VIA EDGAR Jason Drory Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Very truly yours,
BENITEC BIOPHARMA INC.
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD, CALIFORNIA 94545 May 29, 2025 VIA EDGAR Jason Drory Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Benitec Biopharma Inc. Registration Statement on Form S-3 ( File No. 333-287566) Dear Mr. Drory: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287566) so that it may become effective at 4:00 p.m. Eastern Time on June 2, 2025, or as soon thereafter as practicable. Very truly yours, BENITEC BIOPHARMA INC. By: /s/ Dr. Jerel Banks Name: Dr. Jerel Banks Title: Chief Executive Officer cc: Matt O’Loughlin, Proskauer Rose LLP Louis Rambo, Proskauer Rose LLP